Table 1 Characteristics of the UK Biobank cohort and the Luxembourg Parkinson’s Study
Cohort | UK Biobank | Luxembourg Parkinson's study | ||
|---|---|---|---|---|
Diagnostic | Cases | Controls | Cases | Controls |
Participants, n | 1636 | 183,589 | 653 | 767 |
Male, n (%) | 1009 (61.7) | 82,276 (44.8) | 440 (67.4) | 410 (53.5) |
Female,n (%) | 627 (38.3) | 101,313 (55.2) | 213 (32.6) | 357 (46.5) |
Age at Onset, mean (SD) | 64.6 (8.6) | – | 62.4 (11.5) | – |
Age at assessment, mean (SD) | 62.7 (5.3) | 64.1 (8.0) | 67.3 (10.7) | 59.6 (7.12) |
GBA1PVs carriers, n (%) | 145 (8.8) | 8874 (4.8) | 65 (9.9) | 34 (4.4) |
Family history of PD,n (%) | 157 (9.6) | 7799 (4.2) | 186 (28.5) | 253 (33.0) |
